Related Articles
Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway
Relaxin ameliorates high glucose‑induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway
Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
Metformin attenuates angiotensin II‑induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway